---
figid: PMC11816803__ijms-26-00890-g009
figtitle: 'Figure illustrates simplified pathways involved in the development and
  progression of EC based on KEGG BRITE data (BRITE accession ID: K04503, pathway
  map ID: map05213)'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11816803
filename: ijms-26-00890-g009.jpg
figlink: /pmc/articles/PMC11816803/figure/F9/
number: F9
caption: 'The Figure illustrates simplified pathways involved in the development and
  progression of EC based on KEGG BRITE data (BRITE accession ID: K04503, pathway
  map ID: map05213). It outlines the molecular alterations in signaling pathways and
  genetic changes leading to Type I (endometrioid adenocarcinoma) and Type II (serous
  adenocarcinoma) EC, with a focus on Cyclin D1 overexpression. In Type I EC, Cyclin
  D1 is upregulated through β–Catenin-mediated TCF/LEF transcription in the Wnt signaling
  pathway and is influenced by the MAPK pathway. In Type II EC, Cyclin D1 overexpression
  is associated with alterations in the p53 and ErbB signaling pathways'
papertitle: 'Assessment of Cyclin D1 Expression: Prognostic Value and Functional Insights
  in Endometrial Cancer: In Silico Study'
reftext: Marcin Szymański, et al. Int J Mol Sci. 2025 Feb;26(3).
year: '2025'
doi: 10.3390/ijms26030890
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: CCND1 | endometrial cancer | prognostic factor
automl_pathway: 0.8519025
figid_alias: PMC11816803__F9
figtype: Figure
redirect_from: /figures/PMC11816803__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11816803__ijms-26-00890-g009.html
  '@type': Dataset
  description: 'The Figure illustrates simplified pathways involved in the development
    and progression of EC based on KEGG BRITE data (BRITE accession ID: K04503, pathway
    map ID: map05213). It outlines the molecular alterations in signaling pathways
    and genetic changes leading to Type I (endometrioid adenocarcinoma) and Type II
    (serous adenocarcinoma) EC, with a focus on Cyclin D1 overexpression. In Type
    I EC, Cyclin D1 is upregulated through β–Catenin-mediated TCF/LEF transcription
    in the Wnt signaling pathway and is influenced by the MAPK pathway. In Type II
    EC, Cyclin D1 overexpression is associated with alterations in the p53 and ErbB
    signaling pathways'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - CASP9
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - PTK2B
  - BAD
  - ILK
  - RAPGEF5
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CDH1
  - ERBB2
  - EGFR
  - ERBB3
  - ERBB4
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CCND1
  - CCND2
  - CCND3
  - CTSE
  - CTNNB1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - GADD45A
  - BAX
  - BAK1
  - ST13
  - IRF9
  - PTF1A
  - H3P38
  - POLK
  - TENT4A
  - POLL
  - TP53
  - TP63
  - TP73
  - NEU1
  - NEURL1
  - DNA
  - Ras
  - MEK
  - CANCER
  - adenocarcinoma
  - carcinoma
  - ENDOMETRIAL CANCER
  - endometrial hyperplasia
---
